Karuna Therapeutics, Inc. Earnings Per Share (Diluted)
Karuna Therapeutics, Inc. reported Earnings Per Share (Diluted) of -$11.73 per share for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-22.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2024-02-22
- Karuna Therapeutics, Inc. earnings per share, diluted for the quarter ending 2023-12-31 was -$3.01.
- Karuna Therapeutics, Inc. earnings per share, diluted for the quarter ending 2023-09-30 was -$3.16.
- Karuna Therapeutics, Inc. earnings per share, diluted for the quarter ending 2023-06-30 was -$2.75.
- Karuna Therapeutics, Inc. earnings per share, diluted for the quarter ending 2023-03-31 was -$2.80.
- Karuna Therapeutics, Inc. earnings per share, diluted for fiscal 2023 was -$11.73.
- Karuna Therapeutics, Inc. earnings per share, diluted for fiscal 2022 was -$8.74.
- Karuna Therapeutics, Inc. earnings per share, diluted for fiscal 2021 was -$4.94.
- Karuna Therapeutics, Inc. earnings per share, diluted for fiscal 2020 was -$2.59.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|
| 2023-12-31 | -$3.01 derived: net income ÷ weighted average shares · filed 2024-02-22 | -$6.17 derived: net income ÷ weighted average shares · filed 2024-02-22 | -$8.92 derived: net income ÷ weighted average shares · filed 2024-02-22 | -$11.73 10-K · filed 2024-02-22 |
| 2023-09-30 | -$3.16 10-Q · filed 2023-11-02 | -$5.91 derived: net income ÷ weighted average shares · filed 2023-11-02 | -$8.72 10-Q · filed 2023-11-02 | -$10.97 derived: net income ÷ weighted average shares · filed 2024-02-22 |
| 2023-06-30 | -$2.75 10-Q · filed 2023-08-03 | -$5.55 10-Q · filed 2023-08-03 | -$7.78 derived: net income ÷ weighted average shares · filed 2024-02-22 | -$10.18 derived: net income ÷ weighted average shares · filed 2024-02-22 |
| 2023-03-31 | -$2.80 10-Q · filed 2023-05-04 | -$5.02 derived: net income ÷ weighted average shares · filed 2024-02-22 | -$7.40 derived: net income ÷ weighted average shares · filed 2024-02-22 | -$9.60 derived: net income ÷ weighted average shares · filed 2024-02-22 |
| 2022-12-31 | -$2.21 derived: net income ÷ weighted average shares · filed 2024-02-22 | -$4.59 derived: net income ÷ weighted average shares · filed 2024-02-22 | -$6.77 derived: net income ÷ weighted average shares · filed 2024-02-22 | -$8.74 10-K · filed 2024-02-22 |
| 2022-09-30 | -$2.38 10-Q · filed 2023-11-02 | -$4.56 derived: net income ÷ weighted average shares · filed 2023-11-02 | -$6.52 10-Q · filed 2023-11-02 | -$7.49 derived: net income ÷ weighted average shares · filed 2024-02-22 |
| 2022-06-30 | -$2.17 10-Q · filed 2023-08-03 | -$4.13 10-Q · filed 2023-08-03 | -$5.07 derived: net income ÷ weighted average shares · filed 2024-02-22 | -$6.79 derived: net income ÷ weighted average shares · filed 2024-02-22 |
| 2022-03-31 | -$1.95 10-Q · filed 2023-05-04 | -$2.90 derived: net income ÷ weighted average shares · filed 2024-02-22 | -$4.62 derived: net income ÷ weighted average shares · filed 2024-02-22 | -$5.79 derived: net income ÷ weighted average shares · filed 2024-02-22 |
| 2021-12-31 | -$0.94 derived: net income ÷ weighted average shares · filed 2024-02-22 | -$2.66 derived: net income ÷ weighted average shares · filed 2024-02-22 | -$3.83 derived: net income ÷ weighted average shares · filed 2024-02-22 | -$4.94 10-K · filed 2024-02-22 |
| 2021-09-30 | -$1.72 10-Q · filed 2022-11-03 | -$2.89 derived: net income ÷ weighted average shares · filed 2022-11-03 | -$4.00 10-Q · filed 2022-11-03 | |
| 2021-06-30 | -$1.17 10-Q · filed 2022-08-08 | -$2.27 10-Q · filed 2022-08-08 | ||
| 2020-12-31 | -$2.59 10-K · filed 2023-02-23 |